Bvf Partners L P Rain Therapeutics Inc. (RAIN) insider trading activity

RAIN Quotes by TradingView

Bvf Partners L P is Director of Rain Therapeutics Inc.. Currently has a direct ownership of 0 shares of RAIN, which is worth approximately $0. The most recent transaction as insider was on Jan 25, 2024, when has been sold 5,288,617 shares (Non-Voting Common Stock, $0.001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

BVF PARTNERS L P Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 25 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
5,288,617 Reduced 100.0%
0 Non-Voting Common Stoc...
Jan 25 2024
SELL
Disposition due to a tender of shares in a change of control transaction
-
3,288,186 Reduced 100.0%
0 Common Stock, $0.001 p...
Nov 08 2022
BUY
Open market or private purchase
$9,971,387 $5.83 p/Share
1,710,358 Added 83.35%
341,547 Non-Voting Common Stoc...
Jan 07 2022
BUY
Open market or private purchase
$5,956,620 $12.0 p/Share
496,385 Added 72.81%
185,388 Common Stock, $0.001 p...
Jan 06 2022
BUY
Open market or private purchase
$736,116 $12.0 p/Share
61,343 Added 5.1%
1,141,759 Common Stock, $0.001 p...
Sep 21 2021
BUY
Open market or private purchase
$153,800 $13.94 p/Share
11,033 Added 6.07%
170,582 Common Stock, $0.001 p...
Sep 13 2021
BUY
Open market or private purchase
$6,468,516 $16.49 p/Share
392,269 Added 69.77%
169,992 Common Stock, $0.001 p...
Jul 06 2021
BUY
Open market or private purchase
$4,113,276 $15.25 p/Share
269,723 Added 64.34%
149,480 Common Stock, $0.001 p...
Jul 01 2021
BUY
Open market or private purchase
$4,965,416 $15.65 p/Share
317,279 Added 70.54%
132,500 Common Stock, $0.001 p...
May 24 2021
BUY
Open market or private purchase
$21,640 $15.9 p/Share
1,361 Added 1.2%
112,482 Common Stock, $0.001 p...
May 21 2021
BUY
Open market or private purchase
$1,944,457 $15.94 p/Share
121,986 Added 52.06%
112,353 Common Stock, $0.001 p...
May 19 2021
BUY
Open market or private purchase
$274,216 $15.88 p/Share
17,268 Added 14.15%
104,761 Common Stock, $0.001 p...
May 18 2021
BUY
Open market or private purchase
$3,183,430 $16.65 p/Share
191,197 Added 64.85%
103,646 Common Stock, $0.001 p...
May 13 2021
BUY
Open market or private purchase
$827,080 $14.26 p/Share
58,000 Added 38.74%
91,700 Common Stock, $0.001 p...
Apr 26 2021
BUY
Grant, award, or other acquisition
$408,454 $14.9 p/Share
27,413 Added 23.71%
88,226 Common Stock, $0.001 p...
Apr 23 2021
BUY
Grant, award, or other acquisition
$18,214,106 $16.47 p/Share
1,105,896 Added 92.75%
86,479 Common Stock, $0.001 p...
Apr 23 2021
BUY
Conversion of derivative security
-
3,578,262 Added 92.58%
286,691 Non-Voting Common Stoc...
Apr 23 2021
BUY
Conversion of derivative security
-
217,033 Added 92.58%
17,390 Common Stock, $0.001 p...

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CNCE
CONCERT PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
CTIC
CTI BIOPHARMA CORP Healthcare
Director
XENE
Xenon Pharmaceuticals Inc. Healthcare
> 10% Shareholder
ARQL
ARQULE INC
> 10% Shareholder
SNDX
Syndax Pharmaceuticals Inc Healthcare
> 10% Shareholder
XOMA
XOMA Corp Healthcare
Director
IMDZ
IMMUNE DESIGN CORP.
> 10% Shareholder
PIRS
PIERIS PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
GLYC
GLYCOMIMETICS INC Healthcare
> 10% Shareholder
FPRX
FIVE PRIME THERAPEUTICS, INC.
CALA
Calithera Biosciences, Inc. Healthcare
> 10% Shareholder
CYTK
CYTOKINETICS INC Healthcare
MRUS
Merus N.V. Healthcare
> 10% Shareholder
IDYA
IDEAYA Biosciences, Inc. Healthcare
PRNB
Principia Biopharma Inc.
> 10% Shareholder
KYMR
Kymera Therapeutics, Inc. Healthcare
Director
OLMA
Olema Pharmaceuticals, Inc. Healthcare
Director
ELDN
Eledon Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
RPTX
Repare Therapeutics Inc. Healthcare
> 10% Shareholder
CGEM
Cullinan Oncology, Inc. Healthcare
> 10% Shareholder
THRD
Third Harmonic Bio, Inc. Healthcare
> 10% Shareholder
GPCR
Structure Therapeutics Inc.
> 10% Shareholder
MLTX
MoonLake Immunotherapeutics Healthcare
Director
PNT
POINT Biopharma Global Inc. Healthcare
BPL

Bvf Partners L P

Director
San Francisco, CA

Track Institutional and Insider Activities on RAIN

Follow Rain Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAIN shares.

Notify only if

Insider Trading

Get notified when an Rain Therapeutics Inc. insider buys or sells RAIN shares.

Notify only if

News

Receive news related to Rain Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RAIN